4.022 Feb 2024Director of operationsFormer employeeDublin, DublinRecommendCEO approvalBusiness outlookProswork hard to embrace changeConssmaller company with smaller budgetsShow more
5.022 Dec 2022ResearcherCurrent employeeBoston, MARecommendCEO approvalBusiness outlookProseverything work-life balance culture ethicsConsnothing politics management hybrid work payShow moreHelpfulShare
5.07 Apr 2015Anonymous employeeFormer employeeRecommendCEO approvalBusiness outlookProsVery good biopharmaceutical environment with an appropriate mix of industry and academic researchConsPartially government funded with limited long-term job opportunitiesShow moreHelpfulShare